Die dunkle Wahrheit über Melanotan II: Bräune, Sexdrive, Nebenwirkungen

Melanotan II (MT-2) is often called a "tanning peptide"—but in reality, it deeply affects the melanocortin system: tanning, libido, appetite, energy levels, and central effects in the brain. In this evidence-based deep dive, I'll show you what Melanotan II really does, the role of MC1R and MC4R, how medications like afamelanotide (Scenesse) and bremelanotide (Vyleesi) were developed from it—and what risks and side effects its unregulated use entails. 00:00 – Hook: The "Body Upgrade" Peptide Explained 00:29 – What Is Melanotan II Really? 01:11 – Origin & Mechanism of Action (POMC System) 02:13 – Receptors: Why MT2 Has So Many Effects 03:54 – Tan: How MT2 Changes Pigmentation 04:46 – Libido & Erection: The Real Reason for the Hype 06:13 – Appetite & Energy: Influence on Metabolism 08:06 – Motivation & Mental Effects 09:08 – Side Effects & Risks (Critical Part) 10:18 – Dosage, Reality & Conclusion Let me know in the comments which peptide or hormone I should scientifically analyze next – every month I'm giving away a €250 voucher from VitaminVersand24 to one lucky commenter. If you enjoy these evidence-based deep dives, please subscribe and activate notifications so you don't miss the next episodes. If you enjoy these evidence-based deep dives, please subscribe and activate the bell icon so you don't miss any future episodes. ... ADVERTISEMENT 🏋️ Lifestyle & Competition Coaching: ➡️ https://dr-sascha-gail.de 💊 Supplements for Health & Performance: ➡️ https://www.vitaminversand24.com 🏷️ Code: SASCHA 🧑‍⚕️ Hormone Therapy (TRT/HRT) for Men & Women: ➡️ https://www.doctrinus.de 🏷️ Code: SASCHA 🔬 Peptides for Research Purposes: ➡️ https://www.biolabshop.de & https://www.beyond-peptides.com 🏷️ Code: SASCHA 👃 Nose Strips & Mouth Tapes: ➡️ https://www.sniffys.io 🏷️ Code: SASCHA 🏆 Competition accessories & posing gear: ➡️ https://www.competitionvibes.com 🏷️ Code: SASCHA LITERATURE Dorr, R. T., Dvorakova, K., McLean, S., & Hadley, M. E. (1996). Evaluation of pic peptide in a pilot phase I clinical study in humans. Journal of Investigative Dermatology, 106(4), 553-558. Hadley, M. E., & Dorr, R. T. (2006). Melanocortin peptide therapeutics: historical milestones, clinical studies and commercialization. Peptides, 27(4), 921-930. Herraiz, C., & García-Borrón, J.C. (2016). Melanocortin 1 receptor: Structure, function, and regulation. Frontiers in Genetics, 7, 95. Cerdá-Reverter, J. M., & Cone, R. D. (2016). The α-melanocyte-stimulating hormone/melanocortin-1 receptor interaction: A driver of pleiotropic effects beyond pigmentation. Pigment Cell & Melanoma Research, 29(5), 523–539. Farooqi, I. S., Keogh, J. M., Yeo, G. S. H., Lank, E., Cheetham, T., & O'Rahilly, S. (2003). Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. New England Journal of Medicine, 348(12), 1085-1095. Tao, Y.-X. (2010). The melanocortin-4 receptor: Physiology, pharmacology, and pathophysiology. Endocrine Reviews, 31(4), 506-543. Lassalle, M., & Le, L. (2016). Afamelanotide: A review in erythropoietic protoporphyria. American Journal of Clinical Dermatology, 17(4), 387-394. Biolcati, G., et al. (2025). Long-term safety and clinical effectiveness of afamelanotide in erythropoietic protoporphyria: Real-world evidence from a post-authorization safety study. British Journal of Dermatology. U.S. Food and Drug Administration. (2019). VYLEESI (bremelanotide injection) prescribing information (NDA 210557). Silver Spring, MD: FDA. #mt2 #peptides #libido #bodybuilding